# HEALTHEQUITY, INC. (HQY) · Edgar & Edgarette company card

> Healthequity (HQY) grew revenue 9.5% in FY2026 to $1.3 billion, operating margin 24.6% against a 7.9% median for business services, equity 62.3% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1428336 · fiscal year ended 2026-01-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/HQY) · [JSON](https://www.pops4.com/boards/company/HQY.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $1.3B |
| Revenue growth, 1 year | 9.5% |
| Revenue growth per year | 14.8% |
| Operating margin | 24.6% (prior year 13.5%) |
| Net margin | 16.4% |
| Operating cash flow | $457M |
| Capital spending | $2M |
| Free cash flow | $455M |
| Cash | $319M |
| Long-term debt | $957M |
| Total assets | $3.4B |
| Total equity | $2.1B |
| Equity ÷ assets | 62.3% |
| Return on equity | 10.2% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: 3.26 (safe zone)
- Piotroski F: 9 of 9 (strong)
- Beneish M: -2.77 (below the −1.78 line)
- Health Harbor boat: New ship · no warning signs
- Cash Compass: Cash cow later · growing fast, and already turning revenue into cash

## Edgarette's reading

Exposure: revenue $1.3B (FY2026), total debt $957.4M. Experience: revenue up 9.5% on the year, up 14.8% a year over 4 years; operating margin 24.6%, up from 13.5%. Soundness: equity 62.3% of assets, return on equity 10.2%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $1.3B and $1.6B next year (method v4.1: its own 5-year record of growth weighed at 57% against $1B–10B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $1.2B to $1.7B. A statistical range, not company guidance. Against peers (70 filers, $50M+ revenue, services-business services, nec): operating margin 24.6% against a 7.9% median; growth 9.5% against 10.2%.

Range logged 2026-09-26, receipt eb66de481f97c219, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 5, latest 2026-10-09 ([filing](https://www.sec.gov/Archives/edgar/data/1428336/000110465926115084/0001104659-26-115084-index.htm))

## Recent filings

- 8-K · filed 2026-10-09 · 5.02 Departure or Election of Directors; Appointment of Officers · [filing](https://www.sec.gov/Archives/edgar/data/1428336/000110465926115084/0001104659-26-115084-index.htm)
- 8-K · filed 2026-09-30 · 5.02 Departure or Election of Directors; Appointment of Officers; 7.01 Regulation FD Disclosure · [filing](https://www.sec.gov/Archives/edgar/data/1428336/000142833626000045/0001428336-26-000045-index.htm)
- 10-Q · filed 2026-08-27 · [filing](https://www.sec.gov/Archives/edgar/data/1428336/000142833626000041/0001428336-26-000041-index.htm)
- 8-K · filed 2026-08-27 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1428336/000142833626000040/0001428336-26-000040-index.htm)
- 8-K · filed 2026-06-26 · 5.07 Submission of Matters to a Vote of Security Holders; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1428336/000142833626000034/0001428336-26-000034-index.htm)
- 10-Q · filed 2026-05-28 · [filing](https://www.sec.gov/Archives/edgar/data/1428336/000142833626000028/0001428336-26-000028-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001428336.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1428336

## Cite

POPS4, Edgar & Edgarette: HEALTHEQUITY, INC. (HQY) company card, from the company's own SEC filings, accessed 2026-11-02, https://www.pops4.com/boards/company/HQY. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.